After hours

Nutrien Ltd. Common Shares

NTR · NYSE

Analyst Consensus

Hold

20 analysts

$77

Current

—

Low

$79

Average

—

High

Average target implies +2.50% versus the current price.

Analyst Ratings Synthesis

The supplied consensus is Buy across 20 analysts, with a mean price target of $80; consensus low and high targets are not available, so the full spread cannot be measured. Among specifically named analysts, Morgan Stanley is most bullish with an $81 target and Overweight rating, while Mizuho is least bullish with a $75 target and Neutral rating. Both firms recently lowered their targets, and the direction of the documented revisions is therefore negative, although the evidence does not identify a distinct revision during the August 3-4 trading week. The substantive disagreement centers on whether demand and supply risks, plus near-term earnings uncertainty, justify the sharp target reductions or are already reflected in the shares.

Rating Actions

No individual rating actions have been captured for NTRyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Research Reports

Links to freely available third-party research. Outlook labels are our classification of each article's stance, not a rating of our own.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

BERENBERG BANK

BMO CAPITAL MKT

EDWARD JONES

EXANE BNP PARIB

GOLDMAN SACHS

HSBC GLOBAL RES

JP MORGAN SECUR

MIZUHO SECURITI

MORGAN STANLEY

PIPER SANDLER

RAYMOND JMS LTD

RBC CAPITAL

SCOTIABANK

STIFEL NICOLAUS

TD SECURITIES

UBS

WELLS FARGO SEC

ZACKS RESEARCH

Symbol: NTR
Type: Stock
Sector: Industrials
Industry: Agricultural Chemicals
Exchange: NYSE

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

Key Issues

Bullish view

The consensus remains Buy across 20 analysts, with a mean target of $80, indicating that analysts broadly expect Nutrien’s earnings outlook to withstand the identified operating risks.

Bearish view

QuiverQuant attributed the pullback to concerns about demand and supply risks extending beyond this year, while also flagging near-term earnings risk ahead of the August 5 report.

Analyst Consensus

See all

Hold

20 analysts

$77

Current

—

Low

$79

Average

—

High

Average target implies +2.50% versus the current price.

Earnings History

BeatMissNo estimate

Nutrien Ltd. Common Shares

Analyst Consensus

Analyst Ratings Synthesis

Rating Actions

Research Reports

Covering Firms

Peers